Cargando…
PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells
Low water solubility and thus low bioavailability limit the clinical application of fenbendazole (FBZ) as a potential anticancer drug. Solubilizing agents, such as Mobil Composition of Matter Number 41 (MCM) as a drug carrier, can improve the water solubility of drugs. In this study, PEGylated MCM (...
Autores principales: | Esfahani, Maedeh Koohi Moftakhari, Alavi, Seyed Ebrahim, Cabot, Peter J., Islam, Nazrul, Izake, Emad L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540390/ https://www.ncbi.nlm.nih.gov/pubmed/34683898 http://dx.doi.org/10.3390/pharmaceutics13101605 |
Ejemplares similares
-
β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells
por: Koohi Moftakhari Esfahani, Maedeh, et al.
Publicado: (2022) -
Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy
por: Koohi Moftakhari Esfahani, Maedeh, et al.
Publicado: (2022) -
A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2022) -
Tamoxifen Delivery System Based on PEGylated Magnetic MCM-41 Silica
por: Popova, Margarita, et al.
Publicado: (2020) -
Alcohols react with MCM-41 at room temperature and chemically modify mesoporous silica
por: Björklund, Sebastian, et al.
Publicado: (2017)